246 related articles for article (PubMed ID: 26544684)
1. Cardioprotective Effect of Phenytoin on Doxorubicin-induced Cardiac Toxicity in a Rat Model.
Razmaraii N; Babaei H; Mohajjel Nayebi A; Asadnasab G; Ashrafi Helan J; Azarmi Y
J Cardiovasc Pharmacol; 2016 Mar; 67(3):237-45. PubMed ID: 26544684
[TBL] [Abstract][Full Text] [Related]
2. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats.
Razmaraii N; Babaei H; Mohajjel Nayebi A; Assadnassab G; Ashrafi Helan J; Azarmi Y
Adv Pharm Bull; 2016 Sep; 6(3):423-433. PubMed ID: 27766227
[No Abstract] [Full Text] [Related]
4. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P
Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318
[TBL] [Abstract][Full Text] [Related]
5. Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J; De Rosa S; Tammè L; Iaconetti C; Sorrentino S; Polimeni A; Mignogna C; Amorosi A; Spaccarotella C; Yasuda M; Indolfi C
Cardiovasc Diabetol; 2020 May; 19(1):66. PubMed ID: 32414364
[TBL] [Abstract][Full Text] [Related]
6. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
7. The cardioprotective effects of an antiemetic drug, tropisetron, on cardiomyopathy related to doxorubicin.
Alimoradi H; Barzegar-Fallah A; Hassanzadeh G; Mohammadi-Rick S; Asadi F; Delfan B; Abbasi A; Dehpour AR
Cardiovasc Toxicol; 2012 Dec; 12(4):318-25. PubMed ID: 22744232
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats.
Studneva I; Palkeeva M; Veselova O; Molokoedov A; Ovchinnikov M; Sidorova M; Pisarenko O
Cardiovasc Toxicol; 2019 Apr; 19(2):136-146. PubMed ID: 30238355
[TBL] [Abstract][Full Text] [Related]
9. Crocin treatment prevents doxorubicin-induced cardiotoxicity in rats.
Razmaraii N; Babaei H; Mohajjel Nayebi A; Assadnassab G; Ashrafi Helan J; Azarmi Y
Life Sci; 2016 Jul; 157():145-151. PubMed ID: 27297631
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin Improves Doxorubicin-Induced Cardiac Dysfunction by Modulating Hsp70, Akt, and MAPK Signaling Pathways.
Gao G; Jiang S; Ge L; Zhang S; Zhai C; Chen W; Sui S
J Cardiovasc Pharmacol; 2019 Apr; 73(4):223-231. PubMed ID: 30540688
[TBL] [Abstract][Full Text] [Related]
11. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats.
Imbaby S; Ewais M; Essawy S; Farag N
Hum Exp Toxicol; 2014 Aug; 33(8):800-13. PubMed ID: 24648241
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Thiamine Hydrochloride on Cardiac Function, Redox Status and Morphometric Alterations in Doxorubicin-Treated Rats.
Radonjic T; Rankovic M; Ravic M; Zivkovic V; Srejovic I; Jeremic J; Jeremic N; Sretenovic J; Matic S; Jakovljevic V; Nikolic Turnic T
Cardiovasc Toxicol; 2020 Apr; 20(2):111-120. PubMed ID: 31270735
[TBL] [Abstract][Full Text] [Related]
14. A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats.
Chang SA; Lim BK; Lee YJ; Hong MK; Choi JO; Jeon ES
J Korean Med Sci; 2015 May; 30(5):559-68. PubMed ID: 25931786
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat.
Hassanpour Fard M; Ghule AE; Bodhankar SL; Dikshit M
Pharm Biol; 2011 Apr; 49(4):377-82. PubMed ID: 21391840
[TBL] [Abstract][Full Text] [Related]
19. Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy.
Chen X; Chen Y; Bi Y; Fu N; Shan C; Wang S; Aslam S; Wang PW; Xu J
Cardiovasc Drugs Ther; 2007 Oct; 21(5):367-74. PubMed ID: 17924179
[TBL] [Abstract][Full Text] [Related]
20. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]